Windtree Therapeutics Inc /De/ financial data

Symbol
WINT on Nasdaq, WINTW on OTC
Industry
Biological Products, (No Diagnostic Substances)
Location
2600 Kelly Road, Suite 100, Warrington, PA
State of incorporation
DE
Fiscal year end
December 31
Former names
DISCOVERY LABORATORIES INC /DE/ (to 4/18/2016), ANSAN PHARMACEUTICALS INC (to 7/21/1997), ANSAN INC (to 5/15/1996)
Latest financial report
10-K - Q4 2024 - Apr 15, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 35.1 % -84.8%
Debt-to-equity 215 % -44.8%
Return On Equity -21.5 % +92.2%
Return On Assets -6.1 % +89.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.56M shares -61.3%
Common Stock, Shares, Outstanding 256K shares
Entity Public Float 1.9M USD -69.4%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 52.6M shares +1123%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 16.3M USD +95.1%
Operating Income (Loss) -26.1M USD -26.9%
Nonoperating Income (Expense) 24.3M USD +7856%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.79M USD +91.2%
Income Tax Expense (Benefit) -6K USD
Net Income (Loss) Attributable to Parent -1.79M USD +91.2%
Earnings Per Share, Basic -104 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.78M USD -58.8%
Assets, Current 2.57M USD -52.1%
Property, Plant and Equipment, Net 111K USD -39.3%
Operating Lease, Right-of-Use Asset 1.05M USD -27.2%
Goodwill 0 USD
Assets 27.9M USD -14%
Accounts Payable, Current 1.88M USD +132%
Employee-related Liabilities, Current 57K USD -10.9%
Accrued Liabilities, Current 1.71M USD +5.44%
Liabilities, Current 5.72M USD +43.1%
Deferred Income Tax Liabilities, Net 4.53M USD -10.5%
Operating Lease, Liability, Noncurrent 653K USD -43.8%
Other Liabilities, Noncurrent 3.8M USD 0%
Liabilities 14.7M USD -49.3%
Retained Earnings (Accumulated Deficit) -847M USD -0.21%
Stockholders' Equity Attributable to Parent 10M USD +195%
Liabilities and Equity 27.9M USD -14%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.95M USD -17%
Net Cash Provided by (Used in) Financing Activities 1.03M USD +75%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 120M shares 0%
Common Stock, Shares, Issued 256K shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.91M USD +0.78%
Deferred Tax Assets, Valuation Allowance 52.2M USD -71.9%
Deferred Tax Assets, Gross 50.4M USD -72.8%
Operating Lease, Liability 1.16M USD -27.3%
Depreciation 21K USD -8.7%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 1.25M USD -29.8%
Property, Plant and Equipment, Gross 3.94M USD +0.31%
Operating Lease, Liability, Current 508K USD +16.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 581K USD +1.93%
Lessee, Operating Lease, Liability, to be Paid, Year One 570K USD +7.35%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 87K USD -52.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 97K USD -83.3%
Deferred Tax Assets, Operating Loss Carryforwards 39.6M USD -75.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 4.98M shares -0.49%
Lessee, Operating Lease, Liability, to be Paid, Year Four 97K USD -83.3%
Additional Paid in Capital 860M USD +0.99%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 455K USD -64.4%
Interest Expense 51K USD -1.92%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%